3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
6
Recruiting
5
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
152
Glioblastoma
147
Glioma
94
Neuroblastoma
50
Medulloblastoma
33
Central Nervous System Neoplasms
27
Astrocytoma
27
Neoplasms
24
Ependymoma
23
Sarcoma
22
Carcinoma, Non-Small-Cell Lung
22
Neurofibromatosis 1
20
Melanoma
20
Breast Neoplasms
20
Rhabdomyosarcoma
18
Osteosarcoma
18
Sarcoma, Ewing
16
Lung Neoplasms
16
Gliosarcoma
16
Rhabdoid Tumor
15
Oligodendroglioma
15
Wilms Tumor
13
Meningioma
13
Hepatoblastoma
13
Diffuse Intrinsic Pontine Glioma
13
Recurrence
12
Neurofibroma, Plexiform
11
Neoplasm Metastasis
11
Meningeal Carcinomatosis
11
Lymphoma, Non-Hodgkin
11
Interventions
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Ganglioglioma
×
CNS
×
Clear all
NCT03152318
2026-03-04
rQNestin
Dana-Farber Cancer Institute
Phase 1
Active not recruiting
62 enrolled